icon-folder.gif   Conference Reports for NATAP  
  ID Week 2017
Advancing Science, Improving Care
October 4-8 San Diego, CA
Back grey_arrow_rt.gif
Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Weeks in Patients Coinfected With HCV GT 1 and HIV-1
  Reported by Jules Levin
IDWeek2017/IDSA, October 4-8, 2017, San Diego
P Ruane1, P Buggisch2 , A Moreno3, V Isakov4, L Backus5, D Ain1, J Gonzalez-Garcia6, S Naik7, S Mehta7, J Lee7, M Mertens7, J Llewellyn7, M Natha7, K Kersey, A Osinusi, J Slim, K Zhdanov, J Berenguer10, S Zeuzem11
1Ruane Medical and Liver Health Institute, Los Angeles, CA, USA; 2Ifi-Institute for Interdisciplinary Medicine, Hamburg, Germany; 3Hospital Ramon y Cajal Infectious Diseases, Madrid Spain; 4Institute of Nutrition of Russian Academy of Medical Sciences, Moscow, Russian Federation; 5Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA; Hospital Universitario La Paz/IdiPaz Internal Medicine, Madrid Spain; 7Gilead Sciences, Foster City, CA, USA; 8Saint Michaels Medical Center, Newark, NJ, USA; 9Military Medical Academy, St. Petersburg, Russian Federation; 10Hospital General Universitario Gregorio Maranon/IiSGM Infectious Diseases, Madrid, Spain;11Johann Wolfgang Goethe University Medical Center, Frankfurt, Germany